Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ PSCA Monoclonal Antibody (3F4E4)

Mouse Monoclonal Antibody

Supplier:  Invitrogen™ MA548638

Catalog No. FERMA548638


Only null left
Add to Cart

Description

Description

PSCA Monoclonal Antibody for Western Blot, Flow, ELISA

PSCA (Prostate Stem Cell antigen) is a cell surface antigen, which is overexpressed in approximately40% of primary prostate cancers and in as many as 100% of metastatic ones. PSCA is also overexpressed in a majority of transitional cell and pancreatic carcinomas. Antibody directed against PSCA inhibits tumorigenesis, slows tumor growth, prolongs survival and prevents metastasis in a preclinical zenograft model indicating that PSCA may have utility as a prognostic marker and/or therapeutic target in prostate cancer.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

PSCA
Monoclonal
1 mg/mL
PBS with 0.05% sodium azide
O43653
PSCA
Purified recombinant fragment of human PSCA (AA: 1-114) expressed in E. Coli.
100 μg
Primary
Human
Antibody
IgG1
ELISA, Flow Cytometry, Western Blot
3F4E4
Unconjugated
PSCA
2210408B04Rik; caldesmon; CDM; HCAD; H-CAD; LCAD; L-CAD; NAG22; PRO232; prostate stem cell antigen; PSCA; UNQ206; UNQ206/PRO232
Mouse
Protein G
RUO
8000
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.